loader image

Abstract Submission Guideline 

General Information Submission Deadline

  • Submission is only available online at acsasurabaya.com.
  • Submission opens from Tuesday, August 1st 2024, and closes on Saturday, September 14th, 2024, 11:59:59 PM WIB. Please complete the submission before the deadline.

Title

  • The title of the abstract should be within 300 characters.
  • It should be concise and specific, containing no abbreviations and indicating the nature of the investigation.

Please capitalize your title in proper APA style before the submission.

  • Convert your title here to APA style and manually revise
  • Ex : A Challenging Case Report : Vasospastic Acute Limb Ischaemia in a Four Year Old Boy

Author(s)

  • The designation of a single presenter is required to complete a submission.
  • First author, presenter and co-author(s) can be the same person.
  • Each author’s information must be provided for submission. Be sure to proofread carefully as the authors’ information will be included in a CCJ online supplement and on the official website.

 

Once you submit your abstract, a confirmation email will be sent to you (submitter). If your abstract is accepted, the designated presenter will receive further notification emails for the presentation, and the submitter will receive emails for the CCJ issue; Make sure all the contact information is correct.

Categories

Basic info / Requirements

  • Abstracts must be submitted in English.
  • Abstracts consist of 4 sections: Background, Methods, Results, and Conclusions.

Each section is required to contain min 150 char / Max 2200 char (approx. 300-350 words).

 

  • [Optional] In preparation for your possible publication in the CCJ online supplement, please upload up to three images in each section.
  • [Optional] To increase your chance of acceptance, you can upload videos separately, but they will be only accessible during review and won’t be published.

 

Check Before You Submit

  • Abstracts may be entered directly into the site or copied and pasted, however, be sure to check again whether the special characters or symbols are not broken.
  • You can copy and paste an existing Excel table or create a new table using the provided system tools, however, be sure to check again whether the special characters or symbols are not broken.
  • Spaces are included.
  • Use zeros before decimal points: 0.05, not .05
  • Use decimal points, not commas: 0.05, not 0,05
  • Use lowercase “p” values (p < 0.05).
  • Provide a manufacturer name and location in parentheses for all brand or trade names.
  • Never use the underline feature to denote the following symbols: ±, ≤, ≥.
  • Use space between numbers and symbols. (e.g., 3 ± 4, not 3±4; 3 mg, not 3mg).
  • All measurements must include a unit of measure (e.g., systolic blood pressure “140 mmHg”, not just “140”).
  • For brand drugs, include generic names in parentheses.
  • Do not include references, credits, or grant support.

Review

All submitted abstracts will be thoroughly evaluated by official reviewers, and the result will influence the allocation to two different types of sessions – Best Clinical Trials Session and Abstract Presentation Session.

Acceptance Notification

  • The presenters of the accepted abstracts will be notified in 01 October 2024.
  • After the notification, presenters will be informed of their presentation date and time with specific guidelines for the session.

Presentation

  • Accepted abstracts will be allocated to a 1) Best Clinical Trials Session or 2) Moderated Oral Abstract Competition or 3) E-Poster Presentation (Online Only) based on the scores assigned by official reviewers.
  • All accepted abstracts will be published in Scopus Indexed Journal.

 

For every type of presentation, a presenter is required to submit a presentation slide.

 

Session Type

  • Best Clinical Trials Session
    • Abstracts containing novel findings that may improve current practices will be presented at this session.
    • Studies that have been published before will be excluded.
    • All the presenters in the Best Clinical Trials session will get a cash prize.
    • Best Clinical Trials will be published in an online supplement of a Scopus Indexed Journal.

 

  • Moderated Oral Abstract Competition
    • This competition session will be led by prestigious moderators and panelists.
    • The best presenter who gets the highest score from the moderators and panelists will get a cash prize.

 

  • E-Poster Presentation (Online PPT Presentation: E-Science Station)
    • Abstracts assigned to the E-Poster Presentation will be uploaded on E-Science Station, ACSA website.
    • Presenters won’t present their abstract on-site, but a PPT file with audio will be posted online.

Withdrawal

Please email paper.acsa2024@gmail.com  with your submission email and Title to request a withdrawal.

No-Show policy

When you cannot attend the session to present your case, please notify the secretariat in advance via email at paper.acsa2024@gmail.com.  If the presenter fails to show up or sends a replacement without any notification, it may affect the acceptance of Call for Science in future conferences.

Copyright Information

When cases are submitted, we assume that the authors grant copyright to the Congress Organization for publication on the websites
www.acsasurabaya.com. By submitting a case for the conference, the presenter verifies that the case’s content and its conclusion should not have been published in any other meeting before our meeting

GOOD LUCK

Should you have any questions, please contact us at :

Eva 082218760522
Hesti 0895605882012

or

paper.acsa2024@gmail.com